2013
DOI: 10.1016/j.bcp.2012.12.021
|View full text |Cite
|
Sign up to set email alerts
|

l-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
33
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 53 publications
(40 citation statements)
references
References 46 publications
6
33
0
Order By: Relevance
“…L-Carnitine has been shown to have anti-oxidant and protective effects against oxidative damage in different organs or tissues, including the kidney [46][47][48], and to modulate PPAR-g expression [49].…”
Section: Oxidative Stressmentioning
confidence: 99%
“…L-Carnitine has been shown to have anti-oxidant and protective effects against oxidative damage in different organs or tissues, including the kidney [46][47][48], and to modulate PPAR-g expression [49].…”
Section: Oxidative Stressmentioning
confidence: 99%
“…L-carnitine and acetyl -L-carnitine: L-carnitine is a nitrogenous constituent of muscle primarily involved in the oxidation of fatty acids in mammals. Animal studies indicate that carnitine has both systemic anti-hypertensive effects as well as anti-oxidant effects in the heart by upregulation of eNOS and PPAR gamma, inhibition of RAAS, modulation of NF-κB and down regulation of NOX2, NOX4, TGF-β and CTGF that reduces cardiac fibrosis [144,145] . Endothelial function, NO and oxidative defense are improved while oxidative stress and BP are reduced [144][145][146][147] .…”
Section: Proteinmentioning
confidence: 99%
“…Animal studies indicate that carnitine has both systemic anti-hypertensive effects as well as anti-oxidant effects in the heart by upregulation of eNOS and PPAR gamma, inhibition of RAAS, modulation of NF-κB and down regulation of NOX2, NOX4, TGF-β and CTGF that reduces cardiac fibrosis [144,145] . Endothelial function, NO and oxidative defense are improved while oxidative stress and BP are reduced [144][145][146][147] . Human studies on the effects of L-carnitine and acetyl-L-carnitine are limited, with minimal to no change in BP [148][149][150][151][152][153] .…”
Section: Proteinmentioning
confidence: 99%
“…On the other hand, Zambrano et al reported that arterial hypertension-related cardiac fibrosis could be inhibited by L-carnitine through modulation of Peroxisome Proliferator Activated Receptor-γ expression [35].…”
Section: Introductionmentioning
confidence: 99%